Advancements in Minimal Residual Disease Monitoring and Post-Surgical Surveillance in the Germany Liquid Biopsy Sector during 2025
In late 2025, the detection of Minimal Residual Disease (MRD) has become a cornerstone of post-operative care in Germany, helping to identify patients at a high risk of recurrence before tumors become visible on radiographic scans. By monitoring for the persistence of tumor-specific mutations after surgical resection or chemotherapy, oncologists can make informed decisions regarding the...
0 Commentarios 0 Acciones 20 Views 0 Vista previa